Artivion, Inc. (AORT)
25.57
-0.05
(-0.20%)
USD |
NYSE |
Sep 04, 16:00
25.55
-0.02
(-0.08%)
Pre-Market: 20:00
Artivion SG&A Expense (TTM) : 254.77M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 254.77M |
| March 31, 2026 | 232.61M |
| December 31, 2025 | 226.49M |
| September 30, 2025 | 221.08M |
| June 30, 2025 | 213.93M |
| March 31, 2025 | 205.63M |
| December 31, 2024 | 181.72M |
| September 30, 2024 | 180.57M |
| June 30, 2024 | 181.60M |
| March 31, 2024 | 189.45M |
| December 31, 2023 | 209.00M |
| September 30, 2023 | 197.18M |
| June 30, 2023 | 187.14M |
| March 31, 2023 | 168.97M |
| December 31, 2022 | 157.65M |
| September 30, 2022 | 170.42M |
| June 30, 2022 | 168.42M |
| March 31, 2022 | 170.26M |
| December 31, 2021 | 169.97M |
| September 30, 2021 | 154.85M |
| June 30, 2021 | 149.67M |
| March 31, 2021 | 141.26M |
| December 31, 2020 | 141.73M |
| September 30, 2020 | 143.43M |
| June 30, 2020 | 143.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 146.08M |
| December 31, 2019 | 143.40M |
| September 30, 2019 | 141.23M |
| June 30, 2019 | 139.64M |
| March 31, 2019 | 139.75M |
| December 31, 2018 | 140.57M |
| September 30, 2018 | 135.14M |
| June 30, 2018 | 127.03M |
| March 31, 2018 | 115.69M |
| December 31, 2017 | 101.21M |
| September 30, 2017 | 93.26M |
| June 30, 2017 | 89.10M |
| March 31, 2017 | 88.14M |
| December 31, 2016 | 91.55M |
| September 30, 2016 | 88.44M |
| June 30, 2016 | 85.34M |
| March 31, 2016 | 82.23M |
| December 31, 2015 | 74.93M |
| September 30, 2015 | 74.43M |
| June 30, 2015 | 75.82M |
| March 31, 2015 | 74.45M |
| December 31, 2014 | 73.75M |
| September 30, 2014 | 71.79M |
| June 30, 2014 | 69.44M |
| March 31, 2014 | 68.41M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alphatec Holdings, Inc. | 524.06M |
| Globus Medical, Inc. | 1.217B |
| Glaukos Corp. | 386.70M |
| TransMedics Group, Inc. | 218.27M |
| PROCEPT BioRobotics Corp. | 252.06M |